Skip to main content
. 2017 Oct 5;153(2):414–426. doi: 10.1016/j.chest.2017.09.035

Table 2.

Symptoms, Physical Examination Results, Laboratory Test Results, and Other Test Results

Characteristic No. of Patients No IPVD No. of Patients IPVD P Value
Symptoms
Dyspnea, No. (%) 81 15 (18.5) 46 11 (23.9) .47
 Borg score baseline, median (IQR) 69 0 (0-0.5) 41 0 (0-0.5) .64
 Borg score after exercise, median (IQR) 69 2 (0.5-3.0) 41 2 (0.5-3) .99
 Platypnea, No. (%) 81 0 (0.0) 46 2 (4.3) .13
 Orthopnea, No. (%) 81 2 (2.5) 46 2 (4.3) .62
 Edema, No. (%) 81 33 (40.7) 46 24 (52.2) .21
 Palpitations, No. (%) 81 5 (6.2) 46 1 (2.2) .42
 Syncope, No. (%) 81 2 (2.5) 46 0 (0.0) .53
 Angina, No. (%) 81 4 (4.9) 46 2 (4.3) > .99
 WHO functional class, No. (%) 81 46 .84
 1 34 (42.0) 19 (41.3)
 2 36 (44.4) 19 (41.3)
 3 11 (13.6) 8 (17.4)
Physical examination results
 Weight, median (IQR), kg 81 86.1 (75.0-101.0) 46 85.1 (73.2-99.1) .54
 Height, median (IQR), cm 81 173.0 (165.1-178.2) 46 170.5 (165.0-178.8) .40
 BMI, median (IQR), kg/m2 81 28.7 (25.4-35.6) 46 28.7 (25.0-33.3) .85
 Body surface area, median (IQR), m2 81 2.0 (1.9-2.2) 46 2.0 (1.8-2.2) .49
 Systolic BP, mean (SD), mm Hg 81 122.6 (17.6) 46 122.5 (17.3) .99
 Diastolic BP, mean (SD), mm Hg 81 70.3 (12.0) 46 69.4 (10.0) .65
 Respiratory rate, median (IQR) 81 18 (13-18) 45 18 (14-18) .78
 Heart rate, mean (SD) 79 66.0 (14.1) 46 66.3 (10.6) .88
 Seated oxygen saturation, median (IQR), % 81 98 (97-99) 46 99 (97-99) .20
 Supine oxygen saturation, median (IQR), % 81 98 (97-99) 45 99 (97-100) .32
 Clubbing, No. (%) 81 4 (4.9) 46 1 (2.2) .65
 Spider angioma, No. (%) 80 22 (27.5) 46 13 (28.3) .93
 Asterixis, No. (%) 81 3 (3.7) 46 2 (4.3) > .99
 Jaundice, No. (%) 81 16 (19.8) 46 14 (30.4) .17
Laboratory test results, median (IQR)
 Sodium, mEq/L 81 139 (135-140) 46 140 (137-141) .25
 BUN 75 15 (12-20) 43 16 (10-22) .97
 Creatinine, mg/dL 81 1.0 (1.0-1.2) 46 1.0 (1.0-1.1) .04
 Glucose 81 103 (87-138) 46 100(85-132) .79
 Platelets, 1,000/μL 80 93 (64-130) 46 89 (59-135) .51
 Hemoglobin 81 12.3 (11.1-13.6) 46 12.4 (10.4-13.5) .66
 INR 80 1.2 (1.1-1.4) 45 1.4 (1.2-1.5) .008
 Albumin, g/dL 80 3.4 (2.8-3.8) 46 3.1 (2.7-3.4) .07
 Total bilirubin, mg/dL 80 1.2 (1.0-2.4) 46 2.0 (1.5-3.9) .004
 Direct bilirubin, mg/dL 79 0.5 (0.2-0.9) 46 0.8 (0.4-1.4) .02
 Alanine aminotransferase 80 49 (27-73) 46 51 (27-74) .82
 Aspartate aminotransferase 80 54 (36-87) 46 67 (39-96) .43
 Alkaline phosphatase 80 147 (109-203) 46 147 (115-183) .86
Arterial blood gas 81 46
 pH, mean (SD) 7.44 (0.04) 7.44 (0.04) .66
 PaCO2, mean (SD), mm Hg 36.0 (4.6) 34.2 (4.8) .047
 PaO2, median (IQR), mm Hg 89.0 (82.0-96.9) 97.9 (92.0-103.0) < .001
 A-a gradient, median (IQR), mm Hg 14.9 (9.0-21.8) 9.9 (6.2-13.5) < .001
Spirometric results, mean (SD) 81 46
 FVC, L 3.80 (0.92) 3.70 (0.86) .52
 FVC, % predicted 89.2 (12.0) 89.3 (12.9) .98
 FEV1, L 2.95 (0.63) 2.91 (0.63) .74
 FEV1, % predicted 90.7 (11.2) 91.0 (11.7) .90
 FEV1/FVC 0.78 (0.06) 0.79 (0.06) .32
 FEV1/FVC, % predicted 78.4 (5.6) 79.5 (6.4) .32
Echocardiographic results
 Left atrial volume, mean (SD), mL 69 71.0 (19.4) 41 77.9 (23.4) .09
 LV end systolic volume, median (IQR), mL 54 61.5 (53.0-80.0) 35 62.0 (46.0-82.0) .73
 LV end diastolic volume, median (IQR), mL 54 162.5 (135.0-204.0) 35 160.0 (129.0-196.0) .92
 RV systolic area, median (IQR), cm2 31 10.9 (9.1-13.6) 21 11.9 (7.5-13.0) .72
 RV diastolic area, median (IQR), cm2 36 21.7 (16.5-26.5) 26 21.0 (14.6-24.7) .34
 Stroke volume, mean (SD), mL 74 87.7 (26.6) 43 91.8 (22.5) .39
 Stroke volume index, mean (SD), mL/m2 74 43.7 (11.7) 43 46.1 (10.5) .27
 Cardiac output, median (IQR), L/min 74 5.5 (4.5-6.5) 43 6.2 (4.5-6.9) .20
 Cardiac index, mean (SD), L/min/m2 74 2.8 (0.7) 43 3.0 (0.7) .15
 Ejection fraction, mean (SD), % 81 62.3 (6.2) 46 63.4 (6.7) .39
 Right atrial pressure, median (IQR), mm Hg 81 5 (5-10) 46 5 (5-10) .90
 RVSP, median (IQR), mm Hg 50 28 (24-34) 34 30 (24-37) .38
 TAPSE, median (IQR), mm 59 25 (21-29) 39 26 (24-32) .10
 Visual RV function, No. (%) 81 46 .30
 Normal 76 (93.8) 46 (100.0)
 Mild dysfunction 4 (4.9) 0 (0.0)
 Indeterminate 1 (1.2) 0 (0.0)
Exercise capacity 69 41
 6-min walk distance, mean (SD), m 432.4 (88.5) 414.7 (109.9) .36
Quality of life (SF-36) 80 46
 Physical component summary, mean (SD) 37.3 (10.3) 34.8 (11.3) .21
 Physical role, median (IQR) 50 (25-75) 44 (25-75) .37
 Physical functioning, median (IQR) 65 (38-85) 50 (35-75) .30
 Bodily pain, median (IQR) 52 (37-74) 51 (41-74) .89
 General health perception, median (IQR) 40 (25-67) 36 (22-52) .19
 Mental component summary, median (IQR) 48.8 (39.6-55.0) 49.7 (40.3-56.6) .63
 Emotional role, median (IQR) 67 (42-100) 67 (50-100) .39
 Social functioning, median (IQR) 63 (38-94) 63 (50-88) .98
 Mental health, median (IQR) 75 (58-90) 75 (60-85) .93
 Vitality, median (IQR) 44 (25-66) 38 (25-56) .56

Data are presented as mean (SD) for normally distributed continuous variables, median (IQR) for nonnormally distributed continuous variables, or No. (%). Percentages may not sum to 100% because of rounding. A-a = alveolar-arterial; INR = international normalized ratio; LV = left ventricular; RV = right ventricular; RVSP = right ventricular systolic pressure; SF-36 = 36-Item Short Form Survey Instrument; TAPSE = tricuspid annular plane systolic excursion; WHO = World Health Organization. See Table 1 legend for expansion of other abbreviations.